Literature DB >> 6724260

Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat.

J A Barrowman, D N Granger.   

Abstract

In human cirrhosis, there is evidence that there are considerable alterations in fluid and solute exchange in the hepatic and intestinal microcirculations . Experimental cirrhosis was induced in rats by using oral phenobarbitone and carbon tetrachloride inhalation over an 8-wk period. Portal venous pressure, hepatic and intestinal lymph flows, and lymph and plasma protein concentrations were measured. Liver samples were obtained for histologic examination. Portal venous pressure increased from a normal value (control animals) of 9.0 (6.3-13.1) cmH2O to 17.9 (9.0-29.0) cmH2O in cirrhotic rats. There was a strong correlation between the degree of fibrotic change on histology and portal venous pressure. Lymph flows from the intestine and liver in cirrhotic animals were increased threefold and 30-fold, respectively, over values obtained from control animals. There was a good correlation between intestinal and liver lymph flows and portal venous pressure. Analysis of lymph/plasma protein concentration ratios at various lymph flow suggests that capillary permeability in the small intestine during sustained portal hypertension is comparable to that in normal animals. However, the highly permeable blood-lymph barrier of the normal liver becomes markedly restrictive in cirrhotic animals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724260

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Intestinal handling of a glucose gavage by the rat.

Authors:  J A Fernández-López; J Casado; J M Argilés; M Alemany
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

Review 2.  The lymphatics of the liver.

Authors:  M Trutmann; D Sasse
Journal:  Anat Embryol (Berl)       Date:  1994-09

Review 3.  Pathophysiology of portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Clin Liver Dis       Date:  2014-02-25       Impact factor: 6.126

4.  Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites.

Authors:  Masashi Hirooka; Yohei Koizumi; Ryo Yano; Yoshiko Nakamura; Koutarou Sunago; Atsushi Yukimoto; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Masanori Abe; Yoichi Hiasa
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

Review 5.  The lymphatic vascular system in liver diseases: its role in ascites formation.

Authors:  Chuhan Chung; Yasuko Iwakiri
Journal:  Clin Mol Hepatol       Date:  2013-06-27

6.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

Review 7.  The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.

Authors:  Masatake Tanaka; Yasuko Iwakiri
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-14

8.  Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis.

Authors:  Claus Christian Pieper; Andreas Feißt; Carsten Meyer; Julian Luetkens; Michael Praktiknjo; Jonel Trebicka; Ulrike Attenberger; Christian Jansen
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

Review 9.  Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.

Authors:  Ramesh Kumar; Utpal Anand; Rajeev Nayan Priyadarshi
Journal:  World J Hepatol       Date:  2021-03-27

10.  Excretion of Necrotic Hepatocellular Carcinoma Tissues into Hepatic Lymphatic Vessels after Conventional Transarterial Chemoembolization.

Authors:  Shiro Miyayama; Masashi Yamashiro; Rie Ikeda; Junichi Matsumoto; Nobuhiko Ogawa; Naoko Sakuragawa; Teruyuki Ueda
Journal:  Interv Radiol (Higashimatsuyama)       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.